SalioGen Therapeutics is a company developing genetic medicine for patients with inherited disorders. It uses a genetic modification approach that works by adding a new genomic code to turn on, off, or modify function of new or existing genes. The approach is guided by a genome engineering technology that leverages proprietary mammal-derived enzymes.